December 16, 2022
2022 was a noteworthy year for TransCelerate BioPharma, marking the tenth anniversary of our organization. We started with 10 pioneering companies and just five carefully selected projects. Today we are comprised of 20 of the largest multinational biopharmaceutical companies that have demonstrated the ability to create sustainable change in the drug development ecosystem. Our 2022…
Explore
October 20, 2022
2022 marks the Tenth Anniversary of TransCelerate. 150 current and past members, contributors, and other industry stakeholders from around the world convened at the Franklin Institute in Philadelphia on October 6, 2022, to celebrate. At its founding, TransCelerate’s goal was to tackle five persistent issues in clinical trials: development of a shared user interface for…
Explore
May 23, 2022
This October, TransCelerate will mark its 10-year anniversary. As we reflect upon the past decade, we have asked several of our senior leaders and members of our Board of Directors to share their perspectives on the impact of TransCelerate’s work and collaboration as well as our successes and impact within the R&D ecosystem. To begin this series, TransCelerate…
Explore
January 20, 2022
Despite closing out a second year of the COVID-19 pandemic, the R&D ecosystem continued to carry its momentum to modernize clinical trials and make them even more patient-friendly, accessible, and safe. Our 20 Member Companies worked diligently together to create solutions that can transform information flow in clinical development, how sponsors and sites interact with…
Explore
February 11, 2021
Organizations faced the unexpected in 2020 and ours was no exception. We’re proud of our members who worked together to face these new challenges and collaborate on ways new technologies can help us improve the resilience, efficiency and safety of biopharmaceutical research. Our 2020: Year-End Achievements report highlights the launch of new solutions, existing solutions…
Explore
December 15, 2020
Recently, TransCelerate has created the “Leadership Lens,” a new series of videos from leaders of TransCelerate as they discuss the importance and impact of TransCelerate and its work from their perspectives. The new series kicks off with an interview with TransCelerate’s CEO, Dalvir Gill. In his video, Dalvir explains the unique way TransCelerate has positioned…
Explore
August 13, 2020
While a global pandemic is threating the lives of billions, it is more important than ever to improve the public’s understanding of clinical research and how it contributes to a healthier world. As a part of a broader ecosystem composed of passionate and dedicated researchers and scientists interested in solving the toughest health challenges, we…
Explore
